18 results
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
development of HF ... ejection fraction; GDMT ... heart failure; HFpEF ... ejection fraction; HFrEF ... #CHF #Congestive
Heart Failure with Reduced Ejection Fraction (HFrEF) - Guideline Directed Medical Therapy
 • Beta-blocker
 • ACE,
Ejection Fraction (HFrEF ... Heart #Failure #CHF ... #HFrEF #Guideline ... #management #GDMT
Heart Failure with Reduced Ejection Fraction (HFrEF) - Guideline Directed Medical Therapy - Initiation Strategies

 •
Ejection Fraction (HFrEF ... Heart #Failure #CHF ... #HFrEF #Guideline ... #management #GDMT
PAH vs. heart failure with preserved ejection fraction [HFpEF]
#Diagnosis #Pulmonary #Hypertension #PAH #Comparison #Table #HFpEF #DiastolicCHF
ejection fraction [HFpEF ... ] #Diagnosis #Pulmonary ... Hypertension #PAH #Comparison ... #Table #HFpEF #
Algorithm for screening/diagnosis and treatment/follow‐up of iron deficiency in patients with chronic heart failure. Hb, haemoglobin;
treatment/follow‐up of iron ... , haemoglobin; HFrEF ... saturation #Iron ... Management #Diagnosis #HFrEF ... #sCHF #HeartFailure
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Iron Deficiency ... class II and Ill HF ... patients with HFrEF ... #deficiency #CHF ... #HFrEF #heartfailure
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Heart Failure (HFrEF ... Ejection Fraction (HFrEF ... patients with HFrEF ... /ambcarerx #CHF ... #HFrEF #Pharmacology
Diagnostic Algorithm for Treatment of Iron Deficiency in Patients With Heart Failure 

Consensus Recommendations 

#Iron #Deficiency
for Treatment of Iron ... Recommendations #Iron ... Diagnosis #Algorithm #HFrEF ... #sCHF #HeartFailure
HFrEF: Guideline Directed Medical Therapy

"Must Be On"
 • ACEI, ARB, or ARNI AND select Beta Blockers
HFrEF: Guideline ... American patients #hfref ... #medications #chf ... #cardiology #GDMT
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
for SGLT2i in HF ... for SGLT2i in HF ... in HFrEF on GDMT ... outcomes in HFrEF ... on GDMT, with or